Skip to main content
Erschienen in: Head and Neck Pathology 4/2012

01.12.2012 | Original Paper

Acantholytic Squamous Cell Carcinoma in Upper Aerodigestive Tract: Histopathology, Immunohistochemical Profile and Epithelial Mesenchymal Transition Phenotype Change

verfasst von: Xin Gu, Ru Jiang, Marjorie R. Fowler

Erschienen in: Head and Neck Pathology | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Acantholytic squamous cell carcinoma is a rare variant of squamous cell carcinoma in the mucosa of upper aerodigestive tract. Histomorphologically, acantholytic squamous cell carcinoma may lose the typical features of conventional squamous cell carcinoma and mimic other epithelial or mesenchymal malignancies due to advanced acantholysis and dyskeratosis. Because of its rarity, information of prognosis, pathologic features and immunohistochemical profiles is limited. We have studied clinicopathologic features and immunohistochemical profiles of four acantholytic squamous cell carcinoma cases arising from upper aerodigestive tract. Clinical results indicate an aggressive biologic behavior. Morphologically, all tumors revealed significant acantholysis with separation of tumor cells and intratumoral spaces. The tumor cells were highly pleomorphic and growth patterns were variable. In immunohistochemical studies, all tumor cells revealed positive reactions for AE1/AE3 and p63 supporting a squamous epithelial origin. In contrast to conventional aerodigestive squamous cell carcinoma, acantholytic squamous cell carcinoma showed significant reductions of cytokeratin19, E-cadherin and concomitant up-regulation of vimentin expression. Both morphologic features and immunohistochemical profiles indicate that acantholytic squamous cell carcinoma has acquired an epithelial mesenchymal transition phenotype. However, in contrast to other solid malignant tumors, the epithelial mesenchymal transition phenotype change in acantholytic squamous cell carcinoma is not limited to the invasive front of the peripheral tumor but, rather, diffusely involves entire neoplastic lesion. In addition, because cytokeratin 19 staining is attenuated, this would be an insensitive marker for following up and/or in detecting disseminated tumor cells in cases of acantholytic squamous cell carcinoma in upper aerodigestive tract.
Literatur
1.
Zurück zum Zitat Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1998. CA Cancer J Clin. 1998;48:6–29.PubMedCrossRef Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1998. CA Cancer J Clin. 1998;48:6–29.PubMedCrossRef
2.
Zurück zum Zitat Thomas LDR. Squamous cell carcinoma variants of the head and neck. Curr Diagnostic Pathol. 2003;9:384–96.CrossRef Thomas LDR. Squamous cell carcinoma variants of the head and neck. Curr Diagnostic Pathol. 2003;9:384–96.CrossRef
3.
Zurück zum Zitat Cardesa A, Zidar N, Alos L. Acantholytic squamous cell carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005. p. 129. Cardesa A, Zidar N, Alos L. Acantholytic squamous cell carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. Lyon: IARC Press; 2005. p. 129.
4.
Zurück zum Zitat Zidar N, Gale N, Zupevc A, et al. Pseudovascular adenoid squamous-cell carcinoma of the oral cavity—A report of two cases. J Clin Pathol. 2006;59:1206–8.PubMedCrossRef Zidar N, Gale N, Zupevc A, et al. Pseudovascular adenoid squamous-cell carcinoma of the oral cavity—A report of two cases. J Clin Pathol. 2006;59:1206–8.PubMedCrossRef
5.
Zurück zum Zitat Driemel O, Műller-Richter UD, Hakim SG, et al. Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma. Head Face Med. 2008;4:17.PubMedCrossRef Driemel O, Műller-Richter UD, Hakim SG, et al. Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma. Head Face Med. 2008;4:17.PubMedCrossRef
6.
Zurück zum Zitat Yeoh MS, Kim DD, Ghali GE. Acantholytic sqaumous cell carcinoma of the buccal mucosa: Report of a case. J Oral Maxillofac Surg. 2011; Oct 17, E-public ahead of print. Yeoh MS, Kim DD, Ghali GE. Acantholytic sqaumous cell carcinoma of the buccal mucosa: Report of a case. J Oral Maxillofac Surg. 2011; Oct 17, E-public ahead of print.
7.
Zurück zum Zitat Nappi O, Wick MR, Pettinato G, et al. Psuedovascular adenoid squamous cell carcinoma of the skin. A neoplasm that may be mistaken for angiosarcoma. Am J Surg Pathol. 1992;16:429–38.PubMedCrossRef Nappi O, Wick MR, Pettinato G, et al. Psuedovascular adenoid squamous cell carcinoma of the skin. A neoplasm that may be mistaken for angiosarcoma. Am J Surg Pathol. 1992;16:429–38.PubMedCrossRef
8.
Zurück zum Zitat Eusebi V, Lamovec J, Cattani MC, et al. Acantholytic variant of squamous-cell carcinoma of the breast. Am J Surg Pathol. 1986;10:855–61.PubMedCrossRef Eusebi V, Lamovec J, Cattani MC, et al. Acantholytic variant of squamous-cell carcinoma of the breast. Am J Surg Pathol. 1986;10:855–61.PubMedCrossRef
9.
Zurück zum Zitat Johnson WC, Helwig EB. Adenoid squamous cell carcinoma (adenoacanthoma): a clinicopathologic study of 155 patients. Cancer. 1966;19:1639–50.PubMedCrossRef Johnson WC, Helwig EB. Adenoid squamous cell carcinoma (adenoacanthoma): a clinicopathologic study of 155 patients. Cancer. 1966;19:1639–50.PubMedCrossRef
10.
Zurück zum Zitat Papadopoulou E, Tosios KI, Nikitakis N, et al. Acantholytic squamous cell carcinoma of the gingiva: report of a case and review of the literature. Oral Sur Oral Med Oral Pathol Oral Radiol Endod. 2010;109:e67–71.CrossRef Papadopoulou E, Tosios KI, Nikitakis N, et al. Acantholytic squamous cell carcinoma of the gingiva: report of a case and review of the literature. Oral Sur Oral Med Oral Pathol Oral Radiol Endod. 2010;109:e67–71.CrossRef
11.
Zurück zum Zitat Banerjee SS, Eyden BP, Wells S, et al. Pseudoangiosarcomatous carcinoma: a clinicopathological study of seven cases. Histopathology. 1992;21(1):13–23.PubMedCrossRef Banerjee SS, Eyden BP, Wells S, et al. Pseudoangiosarcomatous carcinoma: a clinicopathological study of seven cases. Histopathology. 1992;21(1):13–23.PubMedCrossRef
12.
Zurück zum Zitat Chute DJ, Stelow EB. Cytology of head and neck squamous cell carcinoma variants. Diagn Cytopathol. 2010;38:65–8.PubMed Chute DJ, Stelow EB. Cytology of head and neck squamous cell carcinoma variants. Diagn Cytopathol. 2010;38:65–8.PubMed
13.
Zurück zum Zitat Lever WF. Adenoacanthoma of sweat-gland—Carcinoma of sweat glands with glandular and epidermal elements—Report of four cases. Arch Dermatol. 1947;56:157.CrossRef Lever WF. Adenoacanthoma of sweat-gland—Carcinoma of sweat glands with glandular and epidermal elements—Report of four cases. Arch Dermatol. 1947;56:157.CrossRef
14.
Zurück zum Zitat González-Vela MC, Val-Bernal JF, Mayorga M, et al. Adenoid squamous cell carcinoma of the larynx: an uncommon histological variant of squamous cell carcinoma. APMIS Acta Pathol Moicrobio Immunol Scand. 2006;114:470–3. González-Vela MC, Val-Bernal JF, Mayorga M, et al. Adenoid squamous cell carcinoma of the larynx: an uncommon histological variant of squamous cell carcinoma. APMIS Acta Pathol Moicrobio Immunol Scand. 2006;114:470–3.
15.
Zurück zum Zitat Jones AC, Freedman PD, Kerpel SM. Oral adenoid squamous cell carcinoma: a report of three cases and review of the literature. J Oral Maxillofac Surg. 1993;51:676–81.PubMedCrossRef Jones AC, Freedman PD, Kerpel SM. Oral adenoid squamous cell carcinoma: a report of three cases and review of the literature. J Oral Maxillofac Surg. 1993;51:676–81.PubMedCrossRef
16.
Zurück zum Zitat Jukić Z, Ledinsky I, Ulamec M, et al. Primary acantholytic squamous cell carcinoma of the cecum: a case report. Diagn Pathol. 2011;6:5.PubMedCrossRef Jukić Z, Ledinsky I, Ulamec M, et al. Primary acantholytic squamous cell carcinoma of the cecum: a case report. Diagn Pathol. 2011;6:5.PubMedCrossRef
17.
Zurück zum Zitat Aulmann S, Schnabel PA, Helmchen B, et al. Immunohistochemical and cytogenetic characterization of acantholytic sqaumous cell carcinoma of the breast. Vichows Arch. 2005;446:305–9.CrossRef Aulmann S, Schnabel PA, Helmchen B, et al. Immunohistochemical and cytogenetic characterization of acantholytic sqaumous cell carcinoma of the breast. Vichows Arch. 2005;446:305–9.CrossRef
18.
Zurück zum Zitat Kerawala CJ. Acantholytic squamous cell carcinoma of the oral cavity: a more aggressive entity? Br J Oral Maxillofac Surg. 2009;47:123–5.PubMedCrossRef Kerawala CJ. Acantholytic squamous cell carcinoma of the oral cavity: a more aggressive entity? Br J Oral Maxillofac Surg. 2009;47:123–5.PubMedCrossRef
19.
Zurück zum Zitat Zhong LP, Zhao SF, Chen GF, et al. Increased levels of CK19 mRNA in oral squamous cell carcinoma tissue detected by relative quantification with real-time polymerase chain reaction. Arch Oral Biol. 2006;51:112–9.CrossRef Zhong LP, Zhao SF, Chen GF, et al. Increased levels of CK19 mRNA in oral squamous cell carcinoma tissue detected by relative quantification with real-time polymerase chain reaction. Arch Oral Biol. 2006;51:112–9.CrossRef
20.
Zurück zum Zitat Xu XC, Lee JS, Lippman SM, et al. Increased expression of cytokeratins CK8 and CK19 is associated with head and neck carcinogenesis. Cancer Epidemiol Biomarkers Prev. 1995;4:871–6.PubMed Xu XC, Lee JS, Lippman SM, et al. Increased expression of cytokeratins CK8 and CK19 is associated with head and neck carcinogenesis. Cancer Epidemiol Biomarkers Prev. 1995;4:871–6.PubMed
21.
Zurück zum Zitat Jain R, Fischer S, Serra S, et al. The use of cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver. Appl Immunohistochem Mol Morphol. 2010;18:9–15.PubMedCrossRef Jain R, Fischer S, Serra S, et al. The use of cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver. Appl Immunohistochem Mol Morphol. 2010;18:9–15.PubMedCrossRef
22.
Zurück zum Zitat Eidelman S, Damsky CH, Wheelock MJ, et al. Expression of the cell–cell adhesion glycoprotein cell-CAM 120/80 in normal human tissues and tumors. Am J Pathol. 1989;135:101–10.PubMed Eidelman S, Damsky CH, Wheelock MJ, et al. Expression of the cell–cell adhesion glycoprotein cell-CAM 120/80 in normal human tissues and tumors. Am J Pathol. 1989;135:101–10.PubMed
23.
Zurück zum Zitat Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991 March 22;251(5000):1451–5.CrossRef Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991 March 22;251(5000):1451–5.CrossRef
24.
Zurück zum Zitat Zhao Z, Ge J, Sun Y, et al. Is E-cadherin immunoexpression a prognostic factor for head and neck squamous cell carcinoma (HSCC)? A systematic review and meta-analysis. Oral Oncol. 2012; March 26, Epub ahead of print. Zhao Z, Ge J, Sun Y, et al. Is E-cadherin immunoexpression a prognostic factor for head and neck squamous cell carcinoma (HSCC)? A systematic review and meta-analysis. Oral Oncol. 2012; March 26, Epub ahead of print.
25.
Zurück zum Zitat Savagner P. The epithelial-mesenchymal transition (EMT) phenomenon. Ann Oncol. 2010 Oct; 21 Suppl 7:vii89–vii92. Savagner P. The epithelial-mesenchymal transition (EMT) phenomenon. Ann Oncol. 2010 Oct; 21 Suppl 7:vii89–vii92.
26.
Zurück zum Zitat Willipinski-Stape B, Riethdorf S, Assmann V, et al. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res. 2005;11:8006–14.CrossRef Willipinski-Stape B, Riethdorf S, Assmann V, et al. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res. 2005;11:8006–14.CrossRef
27.
Zurück zum Zitat Jeong H, Ryu YJ, An J, et al. Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype. Histopathology. 2102; Mar 22, Epub ahead of print. Jeong H, Ryu YJ, An J, et al. Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype. Histopathology. 2102; Mar 22, Epub ahead of print.
28.
Zurück zum Zitat Hendrix MJ, Seftor A, Seftor RE, et al. Experimental coexpression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am J Pathol. 1997;150:483–95.PubMed Hendrix MJ, Seftor A, Seftor RE, et al. Experimental coexpression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am J Pathol. 1997;150:483–95.PubMed
29.
Zurück zum Zitat Willipinski-Stapelfeldt B, Riethdorf S, Assmann V, et al. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res. 2005;15:8006–14.CrossRef Willipinski-Stapelfeldt B, Riethdorf S, Assmann V, et al. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res. 2005;15:8006–14.CrossRef
30.
Zurück zum Zitat Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442–54.PubMedCrossRef Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442–54.PubMedCrossRef
31.
Zurück zum Zitat De Wever O, Pauwels P, De Craene B, et al. Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem Cell Biol. 2008;130:481–94.PubMedCrossRef De Wever O, Pauwels P, De Craene B, et al. Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem Cell Biol. 2008;130:481–94.PubMedCrossRef
32.
Zurück zum Zitat Thiery JP, Acloque H, Huang RYJ, et al. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871–90.PubMedCrossRef Thiery JP, Acloque H, Huang RYJ, et al. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871–90.PubMedCrossRef
33.
Zurück zum Zitat Bolos V, Peinado H, Perez-Moreno MA, et al. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci. 2003;116:499–551.PubMedCrossRef Bolos V, Peinado H, Perez-Moreno MA, et al. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci. 2003;116:499–551.PubMedCrossRef
Metadaten
Titel
Acantholytic Squamous Cell Carcinoma in Upper Aerodigestive Tract: Histopathology, Immunohistochemical Profile and Epithelial Mesenchymal Transition Phenotype Change
verfasst von
Xin Gu
Ru Jiang
Marjorie R. Fowler
Publikationsdatum
01.12.2012
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 4/2012
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-012-0391-2

Weitere Artikel der Ausgabe 4/2012

Head and Neck Pathology 4/2012 Zur Ausgabe

Sine qua non Radiology-Pathology

Epithelioid Osteoblastoma

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …